Interaction Checker

Interaksi Albendazol

Albendazol (Albenza) memiliki 74 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 0 mayor, 65 moderat, 9 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Seperti apa tampilan Albendazol

Semua 7 versi
Tablet Albendazol 200 mg: putih, bulat, 12 mm, dengan kode cetak ap di satu sisi dan 550 di sisi lainnya.
ap / 550
200 mg · putih · bulat · 12 mm
Amneal
Tablet Albendazol 400 mg: merah muda, oval, 19 mm, bergaris bagi, dengan kode cetak None.
None
400 mg · merah muda · oval · 19 mm · bergaris bagi
Oasis Trading
Tablet Albendazol 200 mg: putih, bulat, 12 mm, dengan kode cetak 110.
110
200 mg · putih · bulat · 12 mm
Edenbridge
Tablet Albendazol 200 mg: putih, bulat, 12 mm, dengan kode cetak L763.
L763
200 mg · putih · bulat · 12 mm
Alembic

Gambar hasil render dari daftar produk pada label FDA: warna, bentuk, ukuran, dan kode cetak. 7 versi terdokumentasi dari 11 pelabel.

Interaksi dari label

Interaksi moderat (65)

  • Alopurinolpenghambat xantin oksidaseModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • AminofilinmetilxantinModerat

    Theophylline Following a single dose of albendazole (400 mg), the pharmacokinetics of theophylline (aminophylline 5.8 mg/kg infused over 20 minutes) were unchanged. (label Albendazol, Interaksi obat)

  • Asam valproatantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Azelastin dan flutikasonantihistaminModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • BeklometasonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • BetametasonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • BrivarasetamantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • BudesonidkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Budesonid dan formoterolkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Butalbital, aspirin, dan kafeinbarbituratModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • Butalbital, aspirin, kafein, dan kodeinbarbituratModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • Butalbital, parasetamol, dan kafeinbarbituratModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • Butalbital, parasetamol, kafein, dan kodeinbarbituratModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • DeflazakortkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • DeksametasonkortikosteroidModerat

    Dexamethasone: Steady-state trough concentrations of albendazole sulfoxide were about 56% higher when dexamethasone was coadministered with each dose of albendazole. (label Albendazol, Interaksi obat)

  • DesonidkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Divalproeks (valproat)antikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Ergotamin dan kafeinalkaloid ergotModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • EslikarbazepinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • EtosuksimidantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Febuksostatpenghambat xantin oksidaseModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • FelbamatantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FenitoinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FenobarbitalbarbituratModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Fentermin dan topiramatstimulan SSPModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FludrokortisonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FlunisolidkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FluosinonidkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FlutikasonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Flutikason dan salmeterolkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • FosfenitoinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • GabapentinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • HalobetasolkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • HidrokortisonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Kanabidiol (obat resep)antikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • KarbamazepinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • KlobazambenzodiazepinModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • KlobetasolkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • KlonazepambenzodiazepinModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • LakosamidantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • LamotriginantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • LevetirasetamantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • MetilprednisolonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • MetsuksimidantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • MometasonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • OkskarbazepinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Olopatadin dan mometasonantihistaminModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Orfenadrin, aspirin, dan kafeinpelemas ototModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • PentoksifilinmetilxantinModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • PerampanelantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • PrazikuantelModerat

    Praziquantel: In the fed state increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50% in healthy subjects. (label Albendazol, Interaksi obat)

  • PrednisolonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • PrednisonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • PregabalinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • PrimidonantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • RufinamidantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • SenobamatantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • SiklesonidkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • Simetidinpenghambat H2Moderat

    Cimetidine: Increased albendazole sulfoxide concentrations in bile and cystic fluid by about 2-fold in hydatid cyst patients. (label Albendazol, Interaksi obat)

  • TeofilinmetilxantinModerat

    Theophylline: Albendazole induces cytochrome P450 1A in human hepatoma cells; therefore, it is recommended that plasma concentrations of theophylline be monitored during and after treatment. (label Albendazol, Interaksi obat)

  • TiagabinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • TopiramatantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • TriamsinolonkortikosteroidModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • VigabatrinantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

  • ZonisamidantikonvulsanModerat

    Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (label Albendazol, Peringatan dan perhatian)

Penyebutan minor (9)

  • Desogestrel dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Drospirenon dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Estradiol dan dienogestkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Etinodiol diasetat dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Levonorgestrel dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • NoretisteronprogestinMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Noretisteron dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Norgestimat dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

  • Norgestrel dan etinilestradiolkontrasepsi oralMinor

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (label Albendazol, Peringatan dan perhatian)

Periksa Albendazol terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.